Company Profile
- Stock Code
- ERAS
- ISIN Code
- US29479A1088
- Currency
- US Dollar (USD)
- IPO Date
- 2021-07-16

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes ERAS-0015, a pan-RAS molecular glue for the treatment of patients with RAS-mutated solid tumors; ERAS-4001, a pan-KRAS inhibitor for the treatme...